Literature DB >> 11447148

Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

B Rokbi1, D Seguin, B Guy, V Mazarin, E Vidor, F Mion, M Cadoz, M J Quentin-Millet.   

Abstract

Despite increasing knowledge on the biology of Helicobacter pylori, little is known about the expression pattern of its genome during infection. While mouse models of infection have been widely used for the screening of protective antigens, the reliability of the mouse model for gene expression analysis has not been assessed. In an attempt to address this question, we have developed a quantitative reverse transcriptase PCR (RT-PCR) that allowed the detection of minute amounts of mRNA within the gastric mucosa. The expression of four genes, 16S rRNA, ureA (encoding urease A subunit), katA (catalase), and alpA (an adhesin), was monitored during the course of a 6-month infection of mice and in biopsy samples from of 15 infected humans. We found that the selected genes were all expressed within both mouse and human infected mucosae. Moreover, the relative abundance of transcripts was the same (16S rRNA > ureA > katA > alpA), in the two models. Finally, results obtained with the mouse model suggest a negative effect of bacterial burden on the number of transcripts of each gene expressed per CFU (P < 0.05 for 16S rRNA, alpA, and katA). Overall, this study demonstrates that real-time RT-PCR is a powerful tool for the detection and quantification of H. pylori gene expression within the gastric mucosa and strongly indicates that mice experimentally infected with H. pylori provide a valuable model for the analysis of bacterial gene expression during infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447148      PMCID: PMC98562          DOI: 10.1128/IAI.69.8.4759-4766.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.

Authors:  H Kleanthous; G A Myers; K M Georgakopoulos; T J Tibbitts; J W Ingrassia; H L Gray; R Ding; Z Z Zhang; W Lei; R Nichols; C K Lee; T H Ermak; T P Monath
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 2.  Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio.

Authors:  R A Feldman; A J Eccersley; J M Hardie
Journal:  Br Med Bull       Date:  1998       Impact factor: 4.291

3.  Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue.

Authors:  S Odenbreit; M Till; D Hofreuter; G Faller; R Haas
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

4.  Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice.

Authors:  B Guy; C Hessler; S Fourage; B Rokbi; M J Millet
Journal:  Vaccine       Date:  1999-03-05       Impact factor: 3.641

5.  Catalase, a novel antigen for Helicobacter pylori vaccination.

Authors:  F J Radcliff; S L Hazell; T Kolesnikow; C Doidge; A Lee
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Systemic immunization with urease protects mice against Helicobacter pylori infection.

Authors:  B Guy; C Hessler; S Fourage; J Haensler; E Vialon-Lafay; B Rokbi; M J Millet
Journal:  Vaccine       Date:  1998-05       Impact factor: 3.641

7.  Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Authors:  M J Buckley; H X Xia; D M Hyde; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

9.  Free recombination within Helicobacter pylori.

Authors:  S Suerbaum; J M Smith; K Bapumia; G Morelli; N H Smith; E Kunstmann; I Dyrek; M Achtman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

10.  Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Authors:  M Marchetti; M Rossi; V Giannelli; M M Giuliani; M Pizza; S Censini; A Covacci; P Massari; C Pagliaccia; R Manetti; J L Telford; G Douce; G Dougan; R Rappuoli; P Ghiara
Journal:  Vaccine       Date:  1998-01       Impact factor: 3.641

View more
  15 in total

Review 1.  In vivo expression technology.

Authors:  Michael J Angelichio; Andrew Camilli
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Authors:  Anne L Bishop; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils.

Authors:  Olga A Senkovich; Jun Yin; Viktoriya Ekshyyan; Carolyn Conant; James Traylor; Patrick Adegboyega; David J McGee; Robert E Rhoads; Sergey Slepenkov; Traci L Testerman
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

4.  In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer.

Authors:  Francisco Avilés-Jiménez; Adriana Reyes-Leon; Erik Nieto-Patlán; Lori M Hansen; Juan Burgueño; Irma P Ramos; Margarita Camorlinga-Ponce; Hector Bermúdez; Juan M Blancas; Lourdes Cabrera; Rosa María Ribas-Aparicio; Jay V Solnick; Javier Torres-López
Journal:  Infect Immun       Date:  2011-11-28       Impact factor: 3.441

5.  A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.

Authors:  Dirk Bumann; Petra Holland; Frank Siejak; Jan Koesling; Nicolas Sabarth; Stefanie Lamer; Ursula Zimny-Arndt; Peter R Jungblut; Thomas F Meyer
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy.

Authors:  N Sabarth; R Hurwitz; T F Meyer; D Bumann
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 7.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

8.  Differential activities of four Lactobacillus casei promoters during bacterial transit through the gastrointestinal tracts of human-microbiota-associated mice.

Authors:  R Oozeer; J P Furet; N Goupil-Feuillerat; J Anba; J Mengaud; G Corthier
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Helicobacter pylori infection induces interleukin-8 receptor expression in the human gastric epithelium.

Authors:  Fredrik Bäckhed; Elisabeth Torstensson; Delphine Seguin; Agneta Richter-Dahlfors; Bachra Rokbi
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism.

Authors:  Axel Fey; Stefan Eichler; Sébastien Flavier; Richard Christen; Manfred G Höfle; Carlos A Guzmán
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.